INNOLAKE BIOPHARM
Innolake Biopharm clinical-stage biotech company with a focus on oncology and autoimmune disease areas.
INNOLAKE BIOPHARM
Social Links:
Industry:
Biotechnology Medical Therapeutics
Founded:
2020-01-01
Address:
Hangzhou, Zhejiang, China
Country:
China
Website Url:
http://www.innolakebio.com
Total Employee:
1+
Status:
Active
Contact:
+86-21-3886 3300
Email Addresses:
[email protected]
More informations about "Innolake Biopharm"
Innolake Biopharm - Crunchbase Company Profile
Organization. Innolake Biopharm . Connect to CRM . Save . Summary. Financials. People. Signals & News. Similar Companies. ... Contact Email [email protected]; Phone Number +86-21-3886 3300; Innolake Biopharm …See details»
INNOLAKE BIOPHARM
Jun 5, 2023 InnolakeBio’s ADC Product ILB-3101 (globally the first anti-B7H3 ADC with Eribulin as payload) Approved for Clinical Trial. 2024-05-15. SEE MORE. Innolake Filed IND for B7H3 …See details»
INNOLAKE BIOPHARM
Innolake Biopharm is a clinical stage biotech company, dedicated to developing innovative medicines against cancer and autoimmune diseases to improve life of patients around the world.See details»
Innolake Biopharm - LinkedIn
Innolake Biopharm is a clinical stage biotech company, dedicated to developing innovative medicines against cancer and autoimmune diseases to improve the life of patients around the …See details»
Innolake Biopharm - PitchBook
Apr 7, 2021 Innolake Biopharm General Information Description. Developer of therapeutic drugs designed to overcome tumors and immune system diseases. The company is engaged with …See details»
Innolake Biopharm - Products, Competitors, Financials, Employees ...
Apr 12, 2021 innolakebio.com. Overview & Products; Financials; Founded Year 2020. Stage Series A | Alive. Total Raised $58.98M. Last Raised $13.13M | 1 yr ago. About Innolake …See details»
Innolake Pharmaceuticals (Hangzhou) Co., Ltd. - Drug ... - Patsnap
Nov 1, 2024 www.innolakebio.com. Startups | Holding Company | 2020 | Zhejiang Sheng, China | 50-100 | www.innolakebio.com. Last update 01 Nov 2024. Overview. Pipeline. Deal. …See details»
INNOLAKE BIOPHARM
On March 18, 2023, Innolake Biopharm, a company founded just two years ago, was granted the award of “Enterprise of Innovation Breakthrough in 2022” at the 8th Enmore Bio Conference.See details»
Innolake Biopharm | VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and …See details»
Innolake Biopharm - Company Profile - Tracxn
Oct 19, 2024 Innolake Biopharm ranks 1,475th among 2518 active competitors. 908 of its competitors are funded while 575 have exited. Overall, Innolake Biopharm and its competitors …See details»
Innolake Biopharm - VentureRadar
Develops innovative medicines for cancer and autoimmune diseases, co-founded by industry veterans Dr. Mingde Xia and Mr. Robert Chen in 2020. "See details»
Innolake Biopharm Asset Profile - Preqin
Established in 2020 and based in Hangzhou, China, Innolake Biopharm is a medical company that focuses on the research and development of therapeutics in the ...See details»
Innolake Biopharm | Insights
Jan 3, 2025 Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
INNOLAKE BIOPHARM
Jun 5, 2023 Recently, Innolake Biopharm announced the closing of Series A1 financing over RMB100 million jointly led by WuXi Biologics Industry Fund, Heda Fund, and ZBJL Capital.See details»
Innolake Biopharm - Company Profile & Staff Directory - ContactOut
Innolake Biopharm is a clinical stage biotech company, dedicated to developing innovative medicines against cancer and autoimmune diseases to improve the life of patients around the …See details»
Innolake Pharmaceuticals (Hangzhou) Co., Ltd.
了解Innolake Pharmaceuticals (Hangzhou) Co., Ltd. (英诺湖医药（杭州）有限公司)公司的药物管线，治疗领域，技术平台，以及它的4项临床试验, 127篇新闻，疾病领域:肿瘤，免疫系统疾 …See details»
Innolake Biopharm – Funding, Valuation, Investors, News
Innolake Biopharm is a clinical stage biotech company, dedicated to developing innovative medicines against cancer and autoimmune diseases to improve the life of patients around the …See details»
INNOLAKE BIOPHARM
万户网络ezEIP5.0. To innovate for FIC & BIC drugs is the core and spirit of our R&D strategy, while we maintain a healthy balance between potential value and risk control.See details»
项目进展 | 英诺湖医药宣布其新型A2aR选择性拮抗剂ILB-2109完成 …
近日，英诺湖医药(Innolake Biopharm)宣布其拥有全球知识产权的新型A2aR选择性拮抗剂（研发代号：ILB-2109）在治疗晚期实体瘤的I期临床试验中完成首例患者给药。该研 …See details»
INNOLAKE BIOPHARM
At the opening ceremony of the “2021 Nanjing International Summit on Innovation & Investment in Medicine, Life Sciences & Healthcare Industry” on October 20, 2021, the “2021 China …See details»